Jason Madore Selected Research

Jason Madore Research Topics

Disease

24	Neoplasms (Cancer) 10/2020 - 04/2006
15	Melanoma (Melanoma, Malignant) 02/2020 - 05/2015
6	Neoplasm Metastasis (Metastasis) 05/2019 - 05/2012
6	Ovarian Epithelial Carcinoma 06/2013 - 04/2006
4	Breast Neoplasms (Breast Cancer) 01/2019 - 08/2011
4	Ovarian Neoplasms (Ovarian Cancer) 08/2013 - 04/2006
3	Endometrioid Carcinoma 08/2013 - 02/2010
2	Skin Neoplasms (Skin Cancer) 02/2020 - 01/2019
2	Carcinoma (Carcinomatosis) 10/2010 - 02/2010
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2019
1	Inflammation (Inflammations) 01/2017
1	Squamous Cell Carcinoma of Head and Neck 10/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2016
1	Triple Negative Breast Neoplasms 07/2016
1	Carcinogenesis 05/2012
1	Ovarian Diseases (Ovarian Disease) 04/2006

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 12/2018 - 04/2006
6	Immune Checkpoint InhibitorsIBA 10/2020 - 12/2015
5	Biomarkers (Surrogate Marker)IBA 05/2019 - 04/2013
4	LigandsIBA 10/2020 - 08/2011
4	DNA (Deoxyribonucleic Acid)IBA 12/2015 - 04/2006
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 01/2017
2	Niacinamide (Nicotinamide)FDA LinkGeneric 02/2020 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2020 - 04/2013
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2012
2	Histone Deacetylase InhibitorsIBA 01/2018 - 08/2015
2	PanobinostatIBA 01/2018 - 08/2015
2	Adenosine (Adenocard)FDA LinkGeneric 01/2017 - 01/2017
2	EnzymesIBA 01/2017 - 01/2017
2	B7-H1 AntigenIBA 01/2017 - 07/2016
2	Hormones (Hormone)IBA 08/2013 - 08/2011
1	src-Family KinasesIBA 10/2020
1	Tyrosine (L-Tyrosine)FDA Link 10/2020
1	NectinsIBA 10/2020
1	CytokinesIBA 12/2019
1	Adenosine Triphosphate (ATP)IBA 12/2019
1	InflammasomesIBA 12/2019
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 05/2019
1	DisulfidesIBA 12/2018
1	GTP Phosphohydrolases (GTPases)IBA 12/2018
1	Valine (L-Valine)FDA Link 12/2018
1	Cysteine (L-Cysteine)FDA Link 12/2018
1	CaspasesIBA 01/2018
1	Interleukin-15 (Interleukin 15)IBA 01/2018
1	encorafenibIBA 01/2018
1	pembrolizumabIBA 09/2017
1	NivolumabIBA 09/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	trametinibIBA 01/2017
1	dabrafenibIBA 01/2017
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	AntibodiesIBA 10/2016
1	Tumor Viral Antigens (Large T Antigen)IBA 12/2015
1	MART-1 AntigenIBA 09/2015
1	GSK1210151AIBA 08/2015
1	Apoptosis Regulatory ProteinsIBA 08/2015
1	ribosomal protein S4IBA 06/2013
1	Indicators and Reagents (Reagents)IBA 06/2013
1	Cisplatin (Platino)FDA LinkGeneric 06/2013
1	PlatinumIBA 06/2013
1	ParaffinIBA 04/2013
1	IntegrinsIBA 05/2012
1	Phosphotransferases (Kinase)IBA 05/2012
1	AgarIBA 05/2012
1	Small Interfering RNA (siRNA)IBA 05/2012
1	ButyrophilinsIBA 01/2012
1	MethyltransferasesIBA 08/2011
1	Transcription Factors (Transcription Factor)IBA 02/2010
1	WT1 ProteinsIBA 02/2010
1	Interleukin-18 (Interleukin 18)IBA 04/2006
1	Complement System Proteins (Complement)IBA 04/2006
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 04/2006
1	OligonucleotidesIBA 04/2006

Therapy/Procedure

11	Therapeutics 10/2020 - 06/2013
9	Immunotherapy 10/2020 - 05/2015
2	Chemoprevention 02/2020 - 01/2019
1	Drug Therapy (Chemotherapy) 06/2013
1	Injections 05/2012